Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    September 2017
  1. ROSSER A, Pareek M, Turapov O, Wiselka MJ, et al
    Differentially Culturable Tubercule Bacilli are Generated During Non-pulmonary Tuberculosis Infection.
    Am J Respir Crit Care Med. 2017 Sep 7. doi: 10.1164/rccm.201705-1048.
    PubMed     Text format    


    August 2017
  2. LEWINSOHN D
    An Expanding Role for Environmental Microbes in Shaping the Immune Response to Infection with Mycobacterium Tuberculosis.
    Am J Respir Crit Care Med. 2017 Aug 25. doi: 10.1164/rccm.201708-1599.
    PubMed     Text format    


  3. BANAEI N, Pai M
    Detecting New Mycobacterium Tuberculosis Infection: Time for a More Nuanced Interpretation of QuantiFERON Conversions.
    Am J Respir Crit Care Med. 2017 Aug 1. doi: 10.1164/rccm.201707-1543.
    PubMed     Text format    


    July 2017
  4. ABUBAKAR I, Kloprogge F
    End of the Road for Adjunctive Vitamin D Therapy for Pulmonary Tuberculosis?
    Am J Respir Crit Care Med. 2017 Jul 31. doi: 10.1164/rccm.201707-1509.
    PubMed     Text format    


  5. SCRIBA TJ, Carpenter C, Carrasco Pro S, Sidney J, et al
    Differential Recognition of Mtb-specific Epitopes as a Function of Tuberculosis Disease History.
    Am J Respir Crit Care Med. 2017 Jul 31. doi: 10.1164/rccm.201706-1208.
    PubMed     Text format     Abstract available


  6. CLAYTON K, Polak ME, Woelk CH, Elkington P, et al
    Gene Expression Signatures in Tuberculosis Have Greater Overlap with Autoimmune Than Infectious Diseases.
    Am J Respir Crit Care Med. 2017 Jul 28. doi: 10.1164/rccm.201706-1248.
    PubMed     Text format    


  7. NEMES E, Rozot V, Geldenhuys H, Bilek N, et al
    Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of M. tuberculosis Infection.
    Am J Respir Crit Care Med. 2017 Jul 24. doi: 10.1164/rccm.201704-0817.
    PubMed     Text format     Abstract available


  8. LESSELLS RJ, Cooke GS, McGrath N, Nicol MP, et al
    Impact of Point-of-care Xpert MTB/RIF on Tuberculosis Treatment Initiation: A Cluster Randomised Trial.
    Am J Respir Crit Care Med. 2017 Jul 20. doi: 10.1164/rccm.201702-0278.
    PubMed     Text format     Abstract available


  9. GANMAA D, Munkhzul B, Fawzi W, Spiegelman D, et al
    High-Dose Vitamin D3 During Tuberculosis Treatment in Mongolia: A Randomised Controlled Trial.
    Am J Respir Crit Care Med. 2017 Jul 10. doi: 10.1164/rccm.201705-0936.
    PubMed     Text format     Abstract available


    June 2017
  10. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Cryptic Micro-heteroresistance Explains M. tuberculosis Phenotypic Resistance.
    Am J Respir Crit Care Med. 2017 Jun 14. doi: 10.1164/rccm.201703-0556.
    PubMed     Text format     Abstract available


  11. BURZYNSKI J
    The Use of Modeling to Compare Tuberculosis Dynamics in Four US States.
    Am J Respir Crit Care Med. 2017 Jun 13. doi: 10.1164/rccm.201705-0963.
    PubMed     Text format    


  12. GRANDJEAN L
    Investigating the Pathogen Genomic Determinants of Tuberculosis Transmission.
    Am J Respir Crit Care Med. 2017;195:1418-1420.
    PubMed     Text format    



  13. Erratum: New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America: Now Comes the Hard Part.
    Am J Respir Crit Care Med. 2017;195:1540.
    PubMed     Text format    


    May 2017
  14. SHRESTHA S, Hill AN, Marks SM, Dowdy DW, et al
    Comparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texas.
    Am J Respir Crit Care Med. 2017 May 5. doi: 10.1164/rccm.201702-0377.
    PubMed     Text format     Abstract available


  15. SHAH JA, Musvosvi M, Shey M, Horne DJ, et al
    A Functional TOLLIP Variant is Associated with BCG-Specific Immune Responses and Tuberculosis.
    Am J Respir Crit Care Med. 2017 May 2. doi: 10.1164/rccm.201611-2346.
    PubMed     Text format     Abstract available


  16. SCHLUGER NW
    AJRCCM: 100-Year Anniversary. Focus on Tuberculosis.
    Am J Respir Crit Care Med. 2017;195:1112-1114.
    PubMed     Text format    


  17. ALLINSON JP, Mackay AJ, Shah PL
    AJRCCM: 100-Year Anniversary. Special Historical Image Section: Tuberculosis Then and Now.
    Am J Respir Crit Care Med. 2017;195:1118-1123.
    PubMed     Text format    


  18. VAN ZYL-SMIT RN, Esmail A, Bateman ME, Dawson R, et al
    Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
    Am J Respir Crit Care Med. 2017;195:1171-1180.
    PubMed     Text format     Abstract available


    April 2017
  19. DIACON AH, van Brakel E, Lounis N, Meyvisch P, et al
    Triplicate Sputum Cultures for Efficacy Evaluation of Novel Anti-tuberculosis Regimens.
    Am J Respir Crit Care Med. 2017 Apr 27. doi: 10.1164/rccm.201704-0796.
    PubMed     Text format    


    March 2017
  20. DEDICOAT MJ, Gunther G, Crudu V, Duarte R, et al
    Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
    Am J Respir Crit Care Med. 2017 Mar 21. doi: 10.1164/rccm.201612-2585.
    PubMed     Text format    


    February 2017

  21. What is Tuberculosis (TB)?
    Am J Respir Crit Care Med. 2017;195:P7-P8.
    PubMed     Text format    


    December 2016
  22. NEBENZAHL-GUIMARAES H, van Laarhoven A, Farhat MR, Koeken VA, et al
    Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes.
    Am J Respir Crit Care Med. 2016 Dec 20. doi: 10.1164/rccm.201605-1042.
    PubMed     Text format     Abstract available


  23. DARTOIS V, Saito K, Warrier T, Nathan C, et al
    New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges.
    Am J Respir Crit Care Med. 2016;194:1448-1451.
    PubMed     Text format    


    November 2016
  24. LEU JS, Chen ML, Chang SY, Yu SL, et al
    SP110b Controls Host Immunity and Susceptibility to Tuberculosis.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  25. HARAUSZ EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, et al
    New/Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis: Practice-Based Recommendations.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  26. GUGLIELMETTI L, Le Du D, Frechet-Jachym M, Mitnick C, et al
    Preventing Acquired Resistance to Bedaquiline and Delamanid in Multidrug-Resistant Tuberculosis Treatment Requires Optimal Management.
    Am J Respir Crit Care Med. 2016;194:1170-1171.
    PubMed     Text format    


  27. SAUNDERS MJ, Datta S
    Contact Investigation: A Priority for Tuberculosis Control Programs.
    Am J Respir Crit Care Med. 2016;194:1049-1051.
    PubMed     Text format    


    October 2016
  28. VARAINE F, Guglielmetti L, Huerga H, Bonnet M, et al
    Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations.
    Am J Respir Crit Care Med. 2016;194:1028-1029.
    PubMed     Text format    


    September 2016
  29. SMALL PM
    Making Tuberculosis Care and Control Easy Again.
    Am J Respir Crit Care Med. 2016;194:537-538.
    PubMed     Text format    


    August 2016
  30. METERSKY ML, Schluger NW
    New Guidelines for the Treatment of Drug-susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and the Infectious Disease Society of America: Now Comes the Hard Part.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format    


  31. WHALEN CC
    The Replacement Principle of Tuberculosis. Why Prevention Matters.
    Am J Respir Crit Care Med. 2016;194:400-1.
    PubMed     Text format    


  32. FOIS A, Trisolini R, Canu S, Pirina P, et al
    Tuberculosis-induced Fish-scale Degeneration of the Central Airways.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format    


    July 2016
  33. KOENIG SP, Furin J
    Update in Tuberculosis/Pulmonary Infections 2015.
    Am J Respir Crit Care Med. 2016;194:142-6.
    PubMed     Text format    


  34. CHENGALROYEN MD, Beukes GM, Gordhan BG, Streicher EM, et al
    Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Tuberculosis Patients.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  35. ZENNER D, Ashkin D
    Diagnosis of Latent Tuberculosis Infection in HIV-infected Pregnant Women. "Baby Steps" toward Better Tuberculosis Control in Pregnancy.
    Am J Respir Crit Care Med. 2016;193:1332-3.
    PubMed     Text format    


  36. WILKINSON KA, Oni T, Gideon HP, Goliath R, et al
    Activation Profile of Mycobacterium tuberculosis-Specific CD4(+) T Cells Reflects Disease Activity Irrespective of HIV Status.
    Am J Respir Crit Care Med. 2016;193:1307-10.
    PubMed     Text format    


    May 2016
  37. MARTINEZ L, Sekandi JN, Castellanos ME, Zalwango S, et al
    Infectiousness of HIV Seropositive Tuberculosis Patients in a High-burden African Setting.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  38. FARHAT MR, Sultana R, Iartchouk O, Bozeman S, et al
    Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  39. GHASSEMIEH BJ, Attia EF, Koelle DM, Mancuso JD, et al
    Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  40. BUSCH M, Herzmann C, Kallert S, Zimmermann A, et al
    Lipoarabinomannan-responsive Polycytotoxic T Cells are Associated With Protection in Human Tuberculosis.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  41. MANCUSO JD, Diffenderfer JM, Ghassemieh BJ, Horne DJ, et al
    The Prevalence of Latent Tuberculosis Infection in the United States.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


  42. HOFFMANN H, Kohl TA, Hofmann-Thiel S, Merker M, et al
    Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.
    Am J Respir Crit Care Med. 2016;193:337-40.
    PubMed     Text format    


    January 2016
  43. MATHAD JS, Bhosale R, Balasubramanian U, Kanade S, et al
    Quantitative IFN-gamma,IL-2 Response and Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Am J Respir Crit Care Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  44. MATTHEWS K, Deffur A, Ntsekhe M, Syed F, et al
    A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.
    Am J Respir Crit Care Med. 2015;192:1518-1521.
    PubMed     Text format    


    October 2015
  45. KING TC, Upfal M, O'Dea LS
    Reply: Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:1022-1023.
    PubMed     Text format    


  46. OLARU ID, Lange C, Sester M
    Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:1021-1022.
    PubMed     Text format    


  47. CUSUMANO G, Bellofiore S, Montineri A, Emanuele R, et al
    Pott's Disease of the Thoracic Spine and Abscess of the Chest Wall.
    Am J Respir Crit Care Med. 2015;192:e51-2.
    PubMed     Text format    


  48. ELKINGTON P, Zumla A
    Update in Mycobacterium tuberculosis Lung Disease 2014.
    Am J Respir Crit Care Med. 2015;192:793-798.
    PubMed     Text format    


    September 2015
  49. GLEESON LE, Keane J
    First Steps in Biomarker Assessment for Reactivation Risk in Latent Tuberculosis Infection.
    Am J Respir Crit Care Med. 2015;192:534-5.
    PubMed     Text format    


  50. GRIFFITH DE
    Nontuberculous Mycobacterial Disease Research. An End to the Beginning.
    Am J Respir Crit Care Med. 2015;192:535-7.
    PubMed     Text format    


  51. SZYMANSKI EP, Leung JM, Fowler CJ, Haney C, et al
    Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.
    Am J Respir Crit Care Med. 2015;192:618-28.
    PubMed     Text format     Abstract available


    August 2015
  52. MURRAY JF
    Tuberculosis and World War I.
    Am J Respir Crit Care Med. 2015;192:411-4.
    PubMed     Text format    


  53. GOMEZ-PASTRANA D, Dominguez J
    Diagnosis of Tuberculosis in Children Using Mycobacteria-Specific Cytokine Responses. Are There Reasons for Hope?
    Am J Respir Crit Care Med. 2015;192:409-10.
    PubMed     Text format    


  54. BOEREE MJ, Diacon AH, Dawson R, Narunsky K, et al
    A Step toward an Optimized Rifampin Dose Completed.
    Am J Respir Crit Care Med. 2015;192:525-6.
    PubMed     Text format    


  55. MILLER SL
    Upper Room Germicidal Ultraviolet Systems for Air Disinfection Are Ready for Wide Implementation.
    Am J Respir Crit Care Med. 2015;192:407-9.
    PubMed     Text format    


  56. TEBRUEGGE M, Dutta B, Donath S, Ritz N, et al
    Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:485-99.
    PubMed     Text format     Abstract available


  57. GARCIA-BASTEIRO AL, Ismail MR, Carrilho C, Ussene E, et al
    "Pomegranate" Spleen in Disseminated Tuberculosis.
    Am J Respir Crit Care Med. 2015;192:387-388.
    PubMed     Text format    


  58. KING TC, Upfal M, Gottlieb A, Adamo P, et al
    T-SPOT.TB Interferon-gamma Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.
    Am J Respir Crit Care Med. 2015;192:367-73.
    PubMed     Text format     Abstract available


    July 2015
  59. BOTHAMLEY GH
    Fluoroquinolone Preventive Therapy after Exposure to Multidrug-Resistant Tuberculosis? Hopes and Fears.
    Am J Respir Crit Care Med. 2015;192:131-2.
    PubMed     Text format    


  60. GEBHARD A, van den Hof S, Cobelens F
    How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Am J Respir Crit Care Med. 2015;192:117.
    PubMed     Text format    


  61. BASTARD M, Bonnet M, du Cros P, Khamraev AK, et al
    Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Am J Respir Crit Care Med. 2015;192:117-118.
    PubMed     Text format    


  62. MUKHERJEE V, Bender WS, Egan JP 3rd
    Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non-Cystic Fibrosis Bronchiectasis and the Significance of Mycobacterium abscessus subsp. abscessus Isolation during M. avium Complex Lung Disease Therapy.
    Am J Respir Crit Care Med. 2015;192:106-108.
    PubMed     Text format    


  63. BISCHOF JE, Chingsanoon A, Nanthavong P, Vidhamaly S, et al
    Contained Rupture of a Tuberculous Mycotic Aortic Aneurysm Detected by Bedside Ultrasound.
    Am J Respir Crit Care Med. 2015;192:e1-e2.
    PubMed     Text format    


    June 2015
  64. CAMINERO JA, Migliori GB
    Automated Digital Microscopy in New Tuberculosis Diagnostic Algorithms. Can It Boost Case Finding?
    Am J Respir Crit Care Med. 2015;191:1352-3.
    PubMed     Text format    


  65. ESCALANTE P, Peikert T, Van Keulen VP, Erskine CL, et al
    Combinatorial Immunoprofiling in Latent Tuberculosis Infection: Toward Better Risk Stratification.
    Am J Respir Crit Care Med. 2015.
    PubMed     Text format     Abstract available


    May 2015

  66. Erratum: daily rifapentine for treatment of pulmonary tuberculosis: a randomized, dose-ranging trial.
    Am J Respir Crit Care Med. 2015;191:1210.
    PubMed     Text format    


  67. ACCINELLI RA, Romero LR, Garcia RF, Sanchez R, et al
    Sustained Benefit of Community-based Tuberculosis Interventions after 30 Years.
    Am J Respir Crit Care Med. 2015;191:1202-3.
    PubMed     Text format    


  68. VOSKUIL MI, Schlesinger LS
    Toward Resolving the Paradox of the Critical Role of the DosR Regulon in Mycobacterium tuberculosis Persistence and Active Disease.
    Am J Respir Crit Care Med. 2015;191:1103-5.
    PubMed     Text format    


  69. ZUMLA A, Maeurer M
    IFN-gamma Release Assays for Risk Assessment in Contacts of Patients with Tuberculosis in Low-Burden European Countries.
    Am J Respir Crit Care Med. 2015;191:1101-3.
    PubMed     Text format    


  70. MENZIES D
    Finishing what they started: when do researchers' responsibilities end?
    Am J Respir Crit Care Med. 2015;191:977-8.
    PubMed     Text format    


    April 2015
  71. DIACON AH, Dawson R, von Groote-Bidlingmaier F, Symons G, et al
    Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
    Am J Respir Crit Care Med. 2015;191:943-53.
    PubMed     Text format     Abstract available


  72. GROSSET J, Vernon A
    A reader's guide to the bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.
    Am J Respir Crit Care Med. 2015;191:871-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: